Related Experiment Videos
Podocyte injuries exacerbate mesangial proliferative glomerulonephritis
Y Morioka1, H Koike, Y Ikezumi
1Department of Cell Biology, Institute of Nephrology, Faculty of Medicine, Niigata University, Japan.
Kidney International
|December 12, 2001
Summary
Podocyte injury from puromycin aminonucleoside (PAN) exacerbates irreversible mesangial proliferative glomerulonephritis. This study demonstrates PAN-induced podocyte damage leads to significant mesangial alterations and persistent proteinuria in experimental models.
Area of Science:
- Nephrology
- Pathology
- Immunology
Background:
- Mesangial proliferative glomerulonephritis can lead to irreversible kidney damage.
- Podocyte injury is hypothesized to be a key factor in the progression of this condition.
Purpose of the Study:
- To investigate the effect of podocyte injury, induced by puromycin aminonucleoside (PAN), on the development of mesangial alterations in anti-Thy 1.1 glomerulonephritis.
Main Methods:
- Female Wistar rats were administered puromycin aminonucleoside (PAN) followed by anti-Thy 1.1 monoclonal antibody (mAb 1-22-3).
- Doses of PAN (10 mg/100 g BW or 5 mg/100 g BW) and timing of sacrifice (7 days or 8 weeks) were varied.
Main Results:
- Consecutive injections of PAN and mAb 1-22-3 induced irreversible mesangial alterations and persistent proteinuria.
- Even a single dose of 5 mg/100 g BW PAN, when combined with mAb 1-22-3, resulted in significant mesangial changes and proteinuria.
Conclusions:
- Podocyte injury plays a crucial role in exacerbating mesangial proliferation and matrix expansion in glomerulonephritis.
- The experimental model using consecutive PAN and mAb 1-22-3 injections offers a novel approach to study progressive mesangial alterations.